Location History:
- Beerse, BE (2002)
- Boom, BE (2003)
- Sint Amandsberg, BE (2002 - 2004)
- Drongen, BE (2005 - 2008)
Company Filing History:
Years Active: 2002-2008
Title: **Frederik Dirk Deroose: Innovator in Pharmaceutical Development**
Introduction
Frederik Dirk Deroose, an accomplished inventor based in Drongen, Belgium, has significantly contributed to the field of pharmaceutical science. With a portfolio of seven patents, Deroose's work showcases his commitment to developing innovative solutions for various health-related challenges.
Latest Patents
Among his latest patents, Deroose has focused on notable compounds and methods that have therapeutic implications. One such invention involves the development of 4,5-dihydro-isoxazole derivatives and their pharmaceutical uses. The compounds presented in this patent exhibit complexity with distinct formulas, involving combinations of pyridinylidene, amides, ketones, and various cyclic compounds. These inventions hold promise for future medicinal applications.
Another of Deroose's key patents revolves around non-steroidal IL-5 inhibitors, specifically 6-azauracil derivatives. These derivatives are designed to treat eosinophil-dependent inflammatory diseases. The innovations not only include processes and intermediates for their preparation but also extend to pharmaceutical compositions featuring these compounds, further highlighting Deroose's research capabilities in medical applications.
Career Highlights
Throughout his career, Frederik Dirk Deroose has collaborated with prominent pharmaceutical companies, including Janssen Pharmaceutica, where his work has been integral to advancing research in drug development. His innovative ideas and contributions have helped in shaping new therapeutic approaches in medicine.
Collaborations
Deroose has also worked alongside esteemed colleagues like Eddy Jean Edgard Freyne and Jean Fernand Armand Lacrampe. These collaborations have likely enriched his research, allowing for a diverse exchange of ideas and fostering an environment of creativity in innovation.
Conclusion
Frederik Dirk Deroose's dedication to innovation in pharmaceuticals is evident through his extensive patent portfolio and collaborative efforts with leading experts in the field. His contributions are paving the way for future developments that could significantly improve patient care and treatment methodologies.